NEW YORK (GenomeWeb) – Non-profit fundraising organization Stand Up to Cancer (SU2C) announced today the launch of four research projects that will use genetic and other technologies to detect and treat cancer at its earliest stages.

The projects are part of the SU2C Cancer Interception initiative and will specifically focus on lung and pancreatic cancer. They will be be funded with a total of $16.6 million provided by SU2C, the Lustgarten Foundation for Pancreatic Cancer Research, LUNGevity, and the American Lung Association.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Jun
26
Sponsored by
Lexogen

This webinar outlines a study that sought to characterize the landscape of alternative polyadenylation (APA) in the lung cancer transcriptome in order to gain insight into the role of APA in cancer progression.

Jul
10
Sponsored by
Qiagen

This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.

Jul
19
Sponsored by
Thermo Fisher Scientific

This webinar will discuss how ultra-highly sensitive and customizable targeted next-generation sequencing panels are applied in inherited disease research.